Rediff Moneywiz

Hi Guest
Feedback

Refresh

506820 ASTRAZEN Group (A)

AstraZeneca Pharma India Ltd. LIVE on BSE (View NSE)

Add to watchlist

12 Apr,15:42

3398.00
83.20 2.51%

Volume	Prev close	Day's H/L (Rs.)	52wk H/L (Rs.)	Mkt Cap (Rs. Cr)
13,479	3,314.80	3,469.15 - 3,212.00	4,970.00 - 2,455.00	8,495.00

Day

Wk

Mn

6Mn

Yr

HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Refresh

ASTRAZEN

AstraZeneca Pharma India Ltd. LIVE on NSE (View BSE)

Add to watchlist

12 Apr,19:35

3389.95
75.15 2.27%

Volume	Prev close	Day's H/L (Rs.)	52wk H/L (Rs.)	Turnover (Rs. Lacs)
138,122	3314.80	3,470.00 - 3,199.55	4,970.00 - 2,452.25	467,337,168.22

Day

Wk

Mn

6Mn

Yr

HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Realtime news for AstraZeneca Pharma India Ltd. (See all 549 news)

12 April 2021, 22:02

European Medicines Agency issues post-vax adverse-event alert for medics - 20 hour(s) ago

Blood clots linked to AstraZeneca vaccine stem from a rare antibody reaction - 1 day(s) ago

Very Rare...: AIIMS Chief On AstraZeneca Vaccine-Linked Clotting - 1 day(s) ago

WHO says surplus AstraZeneca vaccines in rich nations must go to poor countries - 1 day(s) ago

Oxford/AstraZeneca blood clot risk similar to long-haul flight, says UK minister - 4 day(s) ago

BSE Announcements from AstraZeneca Pharma India Ltd. (See all)

Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - 3 day(s) ago

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 - 3 day(s) ago

Company details for AstraZeneca Pharma India Ltd.

Report Card

PE Ratios

114.76

EPS (Rs.)

28.88

Sales (Rs. Cr)

200.25

Face Value (Rs.)

2

Net Profit
Margin (%)

8.68

Last Bonus

1:1

Last Dividend(%)

100

Return on
Average Equity

19.81

Research Centre

Results: Quarterly | Half Yearly | Annual
Statements: Balance Sheet | P&L | Cash Flow More: Dividend | Bonus | Share Holding | Capital Structures | Ratios

Mutual Funds Invested

Goldman Sachs CNX 500 Fund - Direct Plan - Growth

0.01%

Goldman Sachs CNX 500 Fund - Growth

0.01%

Goldman Sachs CNX 500 Fund - Direct Plan - Dividend

0.01%

Goldman Sachs CNX 500 Fund - Dividend

0.01%

Add to portfolio

Get MoneyWiz
on your webpage

Compare AstraZeneca Pharma India Ltd. with other stocks

Alkem Laboratories Ltd.

2,706.25

Apollo Hospitals Enterprise Ltd.

3,114.35

Dr. Reddy's Laboratories Ltd.

4,690.20

J B Chemicals & Pharmaceuticals Ltd.

1,245.70

Narayana Hrudayalaya Ltd.

429.40

Natco Pharma Ltd.

907.90

Neuland Laboratories Ltd.

2,430.40

Novartis India Ltd.

573.95

Procter & Gamble Health Ltd.

6,289.00

Piramal Enterprises Ltd.

1,803.10

ALL MONEYWIZ PAGES

Close

Add AstraZeneca Pharma India Ltd. to your Portfolio
Date of purchase
Quantity
Purchase price
Exchange	BSE NSE

*Watchlist will be based on BSE values